Flavonoids
Intervention3 papers3 findingsMeSH D005419
- Humans2
Outcomes
2Mortality
downin humans1HR 0.8
1 study
Mortality
downin humans1HR 0.8
Flavonoids decrease mortality in humans (HR 0.80, 95% CI 0.65-0.99).
Humansin CKM stages 3 to 4 (Q4 vs Q1)
Dietary flavonoids link to lower mortality across CKM stages · Medicine · 2 Oct 2026
Cancer mortality
downin humans1HR 0.6
1 study
Cancer mortality
downin humans1HR 0.6
Flavonoids decrease cancer mortality in humans (HR 0.60, 95% CI 0.37-0.96).
Humansin CKM stages 1 to 2 (Q4 vs Q1)
Dietary flavonoids link to lower mortality across CKM stages · Medicine · 2 Oct 2026
Associations
1Cardiovascular-kidney-metabolic syndrome
downin humans1OR 0.53
1 study
Cardiovascular-kidney-metabolic syndrome
downin humans1OR 0.53
Flavonoids lower the risk of cardiovascular-kidney-metabolic syndrome in humans (OR 0.53, 95% CI 0.33-0.83).
Humansstage 2 vs 0 (Q4 vs Q1)
Dietary flavonoids link to lower mortality across CKM stages · Medicine · 2 Oct 2026
Latest
3Dietary flavonoids link to lower mortality across CKM stages
Top-quartile flavonoid intake lowered odds of stage 2 CKM syndrome to an odds ratio of 0.53 versus stage 0 among 10,754 US adults.Top-quartile flavonoid intake lowered odds of stage 2 CKM syndrome to an odds ratio of 0.53 versus stage 0 among 10,754 US adults.